Summary
GlobalData's Medical Devices sector report, “Flow Cytometers - Medical Devices Pipeline Assessment, 2016" provides an overview of Flow Cytometers currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Flow Cytometers pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Flow Cytometers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Flow Cytometers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Flow Cytometers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Becton, Dickinson and Company
Boston University
Cytognos, S.L.
LeukoDx Ltd
NanoCellect Biomedical, Inc.
Sandia Electro-Optics Corporation
University of California, Los Angeles
University of Colorado
University of New Mexico
VeraPulse LLC
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Flow Cytometers Overview 6
3 Products under Development 7
3.1 Flow Cytometers - Pipeline Products by Stage of Development 7
3.2 Flow Cytometers - Pipeline Products by Territory 8
3.3 Flow Cytometers - Pipeline Products by Regulatory Path 9
3.4 Flow Cytometers - Pipeline Products by Estimated Approval Date 10
4 Flow Cytometers - Pipeline Products under Development by Companies 11
4.1 Flow Cytometers Companies - Pipeline Products by Stage of Development 11
4.2 Flow Cytometers - Pipeline Products by Stage of Development 12
5 Flow Cytometers Companies and Product Overview 13
5.1 Becton, Dickinson and Company Company Overview 13
5.1.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Boston University Company Overview 16
5.2.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Cytognos, S.L. Company Overview 17
5.3.1 Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 LeukoDx Ltd Company Overview 18
5.4.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 NanoCellect Biomedical, Inc. Company Overview 19
5.5.1 NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 Sandia Electro-Optics Corporation Company Overview 22
5.6.1 Sandia Electro-Optics Corporation Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 University of California, Los Angeles Company Overview 23
5.7.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 University of Colorado Company Overview 24
5.8.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 University of New Mexico Company Overview 25
5.9.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 VeraPulse LLC Company Overview 26
5.10.1 VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 26
6 Flow Cytometers- Recent Developments 27
6.1 Feb 10, 2016: BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS 27
6.2 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 27
6.3 Jan 25, 2016: IntelliCyt Announces Record 2015 Sales 28
6.4 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 29
6.5 Dec 12, 2015: BD Unveils New BD FACSCelesta Flow Cytometer During the 2015 American Society for Cell Biology Annual Meeting 29
6.6 Dec 10, 2015: Thermo Fisher Scientific Awards 2015 Attune NxT Flow Cytometry Grant to California Cancer Researcher 30
6.7 Nov 04, 2015: BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance 31
6.8 Oct 28, 2015: Novacyt Announces 2015 Half Year Results 32
6.9 Sep 15, 2015: BD Named 2015 Outstanding Corporate Innovator Winner by Product Development and Management Association 34
6.10 Aug 06, 2015: BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015 34
6.11 Jul 20, 2015: Novacyt Raises USD2.16 Million in Private Placement of Shares 36
6.12 Jul 20, 2015: Strong First-half Revenues Completes €3.5m in Bond Refinancing and Launches a €1.7m private placement 36
6.13 Jul 13, 2015: BD Announces Sustainability Goals for 2020 38
6.14 Jul 08, 2015: BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 38
6.15 Jun 29, 2015: Becton, Dickinson Enters into Agreement with FlowJo 39
6.16 Jun 17, 2015: Genedata Enters into Integration Agreement with IntelliCyt 39
6.17 Jun 02, 2015: BD Participates in White House Forum on Antibiotic Stewardship 39
6.18 May 07, 2015: BD Announces Results For 2015 Second Fiscal Quarter 40
6.19 Apr 06, 2015: Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups 41
7 Appendix 43
7.1 Methodology 43
7.2 About GlobalData 45
7.3 Contact Us 46
7.4 Disclaimer 46
1.1 List of Tables
Table 1: Flow Cytometers - Pipeline Products by Stage of Development 7
Table 2: Flow Cytometers - Pipeline Products by Territory 8
Table 3: Flow Cytometers - Pipeline Products by Regulatory Path 9
Table 4: Flow Cytometers - Pipeline Products by Estimated Approval Date 10
Table 5: Flow Cytometers Companies - Pipeline Products by Stage of Development 11
Table 6: Flow Cytometers - Pipeline Products by Stage of Development 12
Table 7: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: BD FACSClearCount CD4 Analyzer - Product Status 14
Table 9: BD FACSClearCount CD4 Analyzer - Product Description 14
Table 10: Sepsis Flow Cytometric Diagnostic System - Product Status 15
Table 11: Sepsis Flow Cytometric Diagnostic System - Product Description 15
Table 12: Boston University Pipeline Products & Ongoing Clinical Trials Overview 16
Table 13: Parallel Microfluidic Flow Cytometer - Product Status 16
Table 14: Parallel Microfluidic Flow Cytometer - Product Description 16
Table 15: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 16: Euroflow PID Tube - Product Status 17
Table 17: Euroflow PID Tube - Product Description 17
Table 18: LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
Table 19: Micro-Flowcytometer System - Product Status 18
Table 20: Micro-Flowcytometer System - Product Description 18
Table 21: NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 22: FlowNostic System - Product Status 19
Table 23: FlowNostic System - Product Description 19
Table 24: Lab-On-A-Chip Flow Cytometer - COST Coding - Product Status 20
Table 25: Lab-On-A-Chip Flow Cytometer - COST Coding - Product Description 20
Table 26: WOLF Cell Sorter - Product Status 21
Table 27: WOLF Cell Sorter - Product Description 21
Table 28: Sandia Electro-Optics Corporation Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: Parallel Flow Cytometer - Product Status 22
Table 30: Parallel Flow Cytometer - Product Description 22
Table 31: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 23
Table 32: Microfluidic Image Cytometry Device - Product Status 23
Table 33: Microfluidic Image Cytometry Device - Product Description 23
Table 34: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 24
Table 35: Flow Cytometry Device - Product Status 24
Table 36: Flow Cytometry Device - Product Description 24
Table 37: University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 25
Table 38: Magnecytometer - Product Status 25
Table 39: Magnecytometer - Product Description 25
Table 40: VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 26
Table 41: Photoacoustic Flow Cytometry Device - Product Status 26
Table 42: Photoacoustic Flow Cytometry Device - Product Description 26
Table 43: Glossary 44
1.2 List of Figures
Figure 1: Flow Cytometers - Pipeline Products by Stage of Development 7
Figure 2: Flow Cytometers - Pipeline Products by Territory 8
Figure 3: Flow Cytometers - Pipeline Products by Regulatory Path 9
Figure 4: Flow Cytometers - Pipeline Products by Estimated Approval Date 10
